W. Winn Chatham

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis

Kenneth G. Saag, Gim Gee Teng, Nivedita M. Patkar et al. · Arthritis Care & Research · 2008 · 1.5K citations

Medicine, Pharmacotherapy, Clinical Medicine +11

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome

Bita Shakoory, Joseph A. Carcillo, W. Winn Chatham et al. · Critical Care Medicine · 2015 · 854 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +15

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Yemil Atisha‐Fregoso, Susan Malkiel, Kristina M. Harris et al. · Arthritis & Rheumatology · 2020 · 208 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Randomized, Double‐Blind, Placebo‐Controlled Trial of the Effect of Vitamin D₃ on the Interferon Signature in Patients With Systemic Lupus Erythematosus

Cynthia Aranow, Diane L. Kamen, Maria Dall’Era et al. · Arthritis & Rheumatology · 2015 · 93 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Clinically significant valvular heart disease in systemic lupus erythematosus

Karin V. Straaton, W. Winn Chatham, William J. Koopman et al. · The American Journal of Medicine · 1988 · 78 citations

Medicine, Cardiology, Internal Medicine +12